Fintel reports that on January 10, 2025, Chardan Capital initiated coverage of Unity Biotechnology (NasdaqGS:UBX) with a Buy recommendation. As of December 23, 2024, the average one-year price target ...
Hosted on MSN
Jones Trading Downgrades Oncolytics Biotech (ONCY)
Fintel reports that on May 16, 2025, Jones Trading downgraded their outlook for Oncolytics Biotech (NasdaqCM:ONCY) from Buy to Hold. Analyst Price Forecast Suggests 582.90% Upside As of May 7, 2025, ...
Fintel reports that on March 18, 2025, Citizens Capital Markets upgraded their outlook for Sana Biotechnology (NasdaqGS:SANA) from Market Perform to Market Outperform. As of March 4, 2025, the average ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results